Table 3.
Group A | Group B | |
---|---|---|
Symptoms score (NIH-CPSI questionnaire 0–43) (±S.D.) |
|
|
Baseline |
21.85 ± 5.23 |
22.56 ± 5.78 |
2 months |
12.00 ± 4.34 |
5.23 ± 2.76 |
4 months |
10.48 ± 4.14 |
4.11 ± 2.32 |
6 months |
13.26 ± 4.88 |
3.67 ± 1.98 |
Pain score (NIH-CPSI questionnaire 0–21) (±S.D.) |
|
|
Baseline |
11.65 ± 3.23 |
12.00 ± 2.78 |
2 months |
6.20 ± 2.35 |
2.13 ± 1.90 |
4 months |
5.82 ± 2.10 |
1.65 ± 1.17 |
6 months |
8.06 ± 2.81 |
1.25 ± 0.99 |
Urinary score (NIH-CPSI questionnaire 0–10) (±S.D.) |
|
|
Baseline |
4.65 ± 2.11 |
4.26 ± 2.28 |
2 months |
2.35 ± 1.35 |
1.34 ± 0.89 |
4 months |
2.10 ± 1.15 |
1.11 ± 0.89 |
6 months |
2.65 ± 1.44 |
1.01 ± 0.76 |
Symptoms (%) |
|
|
Baseline |
76 (100) |
77 (100) |
2 months |
15 (19.7) |
7 (9) |
4 months |
18 (23.7) |
7 (9) |
6 months |
20 (26.3) |
5 (6.5) |
QoL (NIH-CPSI questionnaire 0–12) (±S.D.) |
|
|
Baseline |
5.76 ± 2.44 |
5.66 ± 2.39 |
2 months |
2.89 ± 1.68 |
1.85 ± 1.00 |
4 months |
2.60 ± 1.43 |
1.66 ± 0.95 |
6 months | 3.09 ± 1.74 | 1.40 ± 0.94 |